Log in to save to my catalogue

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for seps...

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for seps...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e330b972dd54f1d9071ee67fbca8cbe

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification

About this item

Full title

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-07, Vol.8 (1), p.15949-15949, Article 15949

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Sepsis, a potentially life-threatening complication of an infection, has the highest burden of death and medical expenses in hospitals worldwide. Leukocyte count and CD64 expression on neutrophils (nCD64) are known to correlate strongly with improved sensitivity and specificity of sepsis diagnosis at its onset. A major challenge is the lack of a ra...

Alternative Titles

Full title

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4e330b972dd54f1d9071ee67fbca8cbe

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e330b972dd54f1d9071ee67fbca8cbe

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms15949

How to access this item